| MeSH term | MeSH ID | Detail |
|---|---|---|
| Bronchopneumonia | D001996 | 7 associated lipids |
| Bronchopulmonary Dysplasia | D001997 | 4 associated lipids |
| Bronchopulmonary Sequestration | D001998 | 3 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Byssinosis | D002095 | 11 associated lipids |
| Carbon Monoxide Poisoning | D002249 | 9 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Cat Diseases | D002371 | 12 associated lipids |
| Cattle Diseases | D002418 | 24 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nell A et al. | [Collection, preparation and storage of human plasma for radioimmunologic determination of thromboxane B2]. | 1988 | Wien. Klin. Wochenschr. | pmid:3242305 |
| Weiss K | [Calcium antagonists: anti-atherosclerotic effect by modification of the prostaglandin system]. | 1988 | Wien. Klin. Wochenschr. | pmid:3071922 |
| Sinzinger H et al. | [Defects in the prostaglandin system. IX. Lipoxygenase defect of thrombocytes in a patient with polycythemia vera]. | 1990 | Wien. Klin. Wochenschr. | pmid:2107637 |
| Oettinger W et al. | [Thromboxane A2 and granulocyte elastase after severe trauma--relationship to complications and survival rates]. | 1989 | Wien. Klin. Wochenschr. | pmid:2609665 |
| Burghuber OC et al. | Hydrogen peroxide induced pulmonary vasoconstriction in isolated rat lungs is attenuated by U60,257, a leucotriene synthesis blocker. | 1986 | Wien. Klin. Wochenschr. | pmid:3518246 |
| Gorczynska E et al. | [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro]. | 1985 | Wiad. Lek. | pmid:3933184 |
| Glushko LV et al. | [An evaluation of the efficacy of antiatherosclerotic agents based on a study of the peripheral blood monocytes]. | 1990 | Vrach Delo | pmid:2168603 |
| Efimov VV and LadnyÄ AI | [Status of the prostacyclin and thromboxane system, lipid metabolism and lipid peroxidation processes in patients with coronary atherosclerosis]. | 1986 | Vrach Delo | pmid:3754994 |
| Aliavi AL | [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct]. | 1988 | Vrach Delo | pmid:3293319 |
| Bagdasarian A et al. | IVIG adverse reactions: potential role of cytokines and vasoactive substances. | 1998 | Vox Sang. | pmid:9501404 |
| Jacobi K et al. | Plasma levels of eicosanoids after transfusion of intraoperatively salvaged blood. | 2000 | Vox Sang. | pmid:10729809 |
| Bassalyk LS et al. | [The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period]. | 1992 | Vopr Onkol | pmid:1300754 |
| Malý J et al. | [Changes in platelet function in patients with arterial hypertension]. | 1995 | Vnitr Lek | pmid:7571480 |
| Spinarová L et al. | [Physical training in patients with chornic heart failure: haemodynamics, effects]. | 2001 | Vnitr Lek | pmid:15635849 |
| Margolis JH et al. | The efficacy of dexamethasone and flunixin meglumine in treating endotoxin-induced changes in calves. | 1987 | Vet. Res. Commun. | pmid:3445446 |
| Atroshi F et al. | Inflammation-related changes in cyclic AMP and cyclic GMP in bovine mastitis. | 1989 | Vet. Res. Commun. | pmid:2561035 |
| Friton GM et al. | Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam. | 2006 | Vet. Rec. | pmid:17056651 |
| McKellar QA et al. | Flunixin pharmacokinetics and serum thromboxane inhibition in the dog. | 1989 | Vet. Rec. | pmid:2763429 |
| Galbraith EA and McKellar QA | Pharmacokinetics and pharmacodynamics of piroxicam in dogs. | 1991 | Vet. Rec. | pmid:1887556 |
| Taylor PM et al. | Pharmacodynamics and pharmacokinetics of flunixin in the cat: a preliminary study. | 1991 | Vet. Rec. | pmid:2035219 |